Literature DB >> 15825082

Increased expression and function of integrins in enterocytes by endotoxin impairs epithelial restitution.

Faisal G Qureshi1, Cynthia Leaphart, Selma Cetin, Jun Li, Anatoly Grishin, Simon Watkins, Henri R Ford, David J Hackam.   

Abstract

BACKGROUND & AIMS: Experimental necrotizing enterocolitis (NEC) is characterized by circulating endotoxin (lipopolysaccharide [LPS]) and impaired enterocyte migration. We hypothesized that LPS increases integrin function and cell-matrix adhesion, leading to impaired enterocyte migration in the pathogenesis of NEC.
METHODS: NEC-like intestinal injury was induced in newborn rats by hypoxia/gavage feedings, and restitution was determined by assessing bromodeoxyuridine-labeled enterocytes along the crypt-villus axis. Newborn mice were injected with 5 mg/kg LPS. IEC-6 cells were treated with LPS +/- LY294002 or wortmannin, and beta 1- and alpha 3-integrins were assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunofluorescence. Beta 1-integrin function was determined by adherence of fibronectin beads to IEC-6 monolayers. Migration of IEC-6 cells into a scraped wound was measured by time-lapse microscopy.
RESULTS: Newborn intestinal injury was associated with decreased intestinal restitution and increased alpha 3- and beta 1-integrin expression in the ileal mucosa, which also was observed after LPS injection. In IEC-6 cells, LPS caused an increase in the expression of alpha 3- and beta 1-integrins, a shift of beta 1-integrins from the cytoplasm to the plasma membrane and an increase in fibronectin bead adhesion during which beta 1-integrins accumulated underneath attached beads. These effects could be reversed with LY294002 or wortmannin, suggesting phosphatidylinositol-3-phosphate kinase (PI3K) dependence. The increased integrin-matrix adhesion by LPS led to an inhibition of enterocyte migration, which could be reversed by anti-beta 1-antibodies.
CONCLUSIONS: Enterocyte migration is inhibited by LPS through increased expression and function of alpha 3- and beta 1-integrins. Modulation of enterocyte migration via integrins may provide novel insights into the pathogenesis of NEC, in which intestinal restitution is impaired.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15825082     DOI: 10.1053/j.gastro.2005.01.052

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  41 in total

1.  Nucleotide-binding oligomerization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium.

Authors:  Ward M Richardson; Chhinder P Sodhi; Anthony Russo; Richard H Siggers; Amin Afrazi; Steven C Gribar; Matthew D Neal; Shipan Dai; Thomas Prindle; Maria Branca; Congrong Ma; John Ozolek; David J Hackam
Journal:  Gastroenterology       Date:  2010-05-24       Impact factor: 22.682

2.  Rapid protein kinase D1 signaling promotes migration of intestinal epithelial cells.

Authors:  Steven H Young; Nora Rozengurt; James Sinnett-Smith; Enrique Rozengurt
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-17       Impact factor: 4.052

3.  LPS-binding protein enables intestinal epithelial restitution despite LPS exposure.

Authors:  Juli M Richter; Brandon L Schanbacher; Hong Huang; Jianjing Xue; John A Bauer; Peter J Giannone
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-05       Impact factor: 2.839

4.  Rotavirus replication in intestinal cells differentially regulates integrin expression by a phosphatidylinositol 3-kinase-dependent pathway, resulting in increased cell adhesion and virus yield.

Authors:  Peter Halasz; Gavan Holloway; Stephen J Turner; Barbara S Coulson
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

5.  Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis.

Authors:  Chhinder P Sodhi; Xia-Hua Shi; Ward M Richardson; Zachary S Grant; Richard A Shapiro; Thomas Prindle; Maria Branca; Anthony Russo; Steven C Gribar; Congrong Ma; David J Hackam
Journal:  Gastroenterology       Date:  2009-09-26       Impact factor: 22.682

6.  Animal models of gastrointestinal and liver diseases. Animal models of necrotizing enterocolitis: pathophysiology, translational relevance, and challenges.

Authors:  Peng Lu; Chhinder P Sodhi; Hongpeng Jia; Shahab Shaffiey; Misty Good; Maria F Branca; David J Hackam
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-24       Impact factor: 4.052

7.  Toll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 up-regulated modulator of apoptosis.

Authors:  Matthew D Neal; Chhinder P Sodhi; Hongpeng Jia; Mitchell Dyer; Charlotte E Egan; Ibrahim Yazji; Misty Good; Amin Afrazi; Ryan Marino; Dennis Slagle; Congrong Ma; Maria F Branca; Thomas Prindle; Zachary Grant; John Ozolek; David J Hackam
Journal:  J Biol Chem       Date:  2012-09-06       Impact factor: 5.157

8.  Extracellular high mobility group box-1 (HMGB1) inhibits enterocyte migration via activation of Toll-like receptor-4 and increased cell-matrix adhesiveness.

Authors:  Shipan Dai; Chhinder Sodhi; Selma Cetin; Ward Richardson; Maria Branca; Matthew D Neal; Thomas Prindle; Congrong Ma; Richard A Shapiro; Bin Li; James H-C Wang; David J Hackam
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

9.  A critical role for TLR4 induction of autophagy in the regulation of enterocyte migration and the pathogenesis of necrotizing enterocolitis.

Authors:  Matthew D Neal; Chhinder P Sodhi; Mitchell Dyer; Brian T Craig; Misty Good; Hongpeng Jia; Ibrahim Yazji; Amin Afrazi; Ward M Richardson; Donna Beer-Stolz; Congrong Ma; Thomas Prindle; Zachary Grant; Maria F Branca; John Ozolek; David J Hackam
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

Review 10.  Mechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: Toll-like receptors throw the switch.

Authors:  David J Hackam; Misty Good; Chhinder P Sodhi
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.